Right. Why would you only do 25, 50, and 100mg. The limit is 150mg, and they could still go the prescription route (rather than over the counter) if it is effective for higher than 150mg. Why would they stop at 100mg? Waste of time. Bad clinical trial design shows they don't know medicine. They're in it for the green-rush aspect, and failing. Sad.
Ann: S3 Trial update, page-17
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
0.001(3.33%) |
Mkt cap ! $14.47M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.2¢ | 3.0¢ | $32.13K | 1.035M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 1259746 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.1¢ | 53594 | 1 |
View Market Depth
| Last trade - 15.28pm 17/07/2024 (20 minute delay) ? |
| CAN (ASX) Chart |